Search

Memorial Sloan Kettering has named three winners of this year’s Paul Marks Prize for Cancer Research, an award that recognizes promising investigators.

… Friday, November 8, 2019 Summary The Paul Marks Prize for Cancer Research, first awarded in 2001, recognizes promising scientists who have made important contributions to the study of cancer. Memorial Sloan Kettering has named three investigators as the recipients of this year’s Paul Marks Prize for

Learn how CAR T cell therapy and the expertise of MSK gave Guillaume Arnould another option for treating multiple myeloma, after other therapies failed.

… Tuesday, November 7, 2023 Shortly after finding out his wife was pregnant with their son, Guillaume Arnould got terrible news about his own health: He had multiple myeloma , a rare blood cancer. He was just 33 years old. The following six years were a grueling succession of stem cell transplants stem

Meet Matthew Solowsky, a Navy veteran and Senior Research Technician in the Center for Molecular Oncology at Memorial Sloan Kettering Cancer Center.

… Thursday, November 11, 2021 Matthew Solowsky says he has always been driven and focused. “The hardships from my childhood made me want to rise above circumstances that were outside of myself,” says Mr. Solowsky, who is now a Senior Research Technician in the Center for Molecular Oncology (CMO)  at Memorial

Bispecific antibodies bind to two antigens or two parts of the same antigen at the same time. The U.S. Food and Drug Administration (FDA) recently approved two CD20xCD3 bispecific antibodies —mosunetuzumab (mosun) for patients with relapsed or refractory follicular lymphoma and glofitamab (glofit) for patients with relapsed or refractory diffuse B cell lymphoma (DLBCL) or large B cell lymphoma (LBCL) treated with two or more prior lines of therapy.

… Monday, December 11, 2023 Bispecific antibodies bind to two antigens or two parts of the same antigen at the same time. The U.S. Food and Drug Administration (FDA) recently approved two CD20xCD3 bispecific antibodies —mosunetuzumab (mosun) for patients with relapsed or refractory follicular lymphoma

Meet author Amy Blumenfeld, whose experience as a pediatric patient at Memorial Sloan Kettering inspired her first novel, The Cast.

… Friday, November 16, 2018 Summary In 1989, 15-year-old Amy Blumenfeld was treated for Hodgkin lymphoma at Memorial Sloan Kettering. Her first novel, The Cast, is loosely based on her experience. In the late 1980s, when she was 13, Amy Blumenfeld was diagnosed with Hodgkin lymphoma. She had 11 months

A first-in-class allogeneic CAR T cell therapy regimen demonstrated feasibility and acceptable safety with preliminary evidence of efficacy in patients with heavily pretreated multiple myeloma, according to interim results from the phase 1 UNIVERSAL trial (NCT04093596) published recently in Nature Medicine.

… Wednesday, February 15, 2023 A first-in-class allogeneic CAR T cell therapy regimen demonstrated feasibility and acceptable safety with preliminary evidence of efficacy in patients with heavily pretreated multiple myeloma, according to interim results from the phase 1 UNIVERSAL trial ( NCT04093596 )

NBC News anchor Craig Melvin led MSK experts in a discussion about racial and age trends in colorectal cancer and when people should start screening for the disease.

… Monday, September 19, 2022 NBC News’ Today Show anchor and co-host Craig Melvin led a discussion at Memorial Sloan Kettering Cancer Center (MSK) in March 2022 with colorectal oncologists  Fiyinfolu Balogun  and  Andrea Cercek and gastroenterologist  Robin Mendelsohn . Drs. Cercek and Mendelsohn are Co-Directors

R1 RCM Inc. and Memorial Sloan Kettering today announced a collaboration to develop a new, personalized digital financial experience for patients.

… Monday, November 1, 2021 R1 RCM Inc. (NASDAQ: RCM), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, through its recent acquisition of VisitPay, today announced a collaboration with Memorial Sloan Kettering Cancer

A clinical trial at MSK found that music therapy for cancer-related anxiety is as effective as cognitive behavioral therapy and produces long-lasting benefits.

… Tuesday, January 6, 2026 Anxiety was not new to Cynthia Malaran when she was diagnosed with breast cancer , at the age of 39. The professional DJ and writer from New York City had seen a therapist to help with her feelings of anxiety in the past, but a cancer diagnosis and treatment had made it harder

At MSK, our goal is not just to train the scientists of tomorrow, but the scientific leaders.

… Monday, September 18, 2023 When Direna Alonso-Curbelo, PhD, was a graduate student in Madrid, she had the opportunity to visit Memorial Sloan Kettering Cancer Center (MSK) for a summer-long internship. That gave her a taste of what it was like to live and breathe science at one of the world’s premier